TrialHelicobacter

Efficacy and Safety of Fexuprazan-Based Modified High-Dose Dual Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial.

Ji Yong Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.